Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization

Journal of Neurochemistry

Volumn 123, Issue 2, 2012, Pages 288-297

  German, Christopher L ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

amphetamine; dopamine transporter; internalization; methamphetamine; relocalization; striatum

Indexed keywords

AMPHETAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; ENDOSOME; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RAT;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 84867067969     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07875.x     Document Type: Article

References (36)

1. Berman S. B., Zigmond M. J., and, Hastings T. G., (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593-600.
2. Binda F., Dipace C., Bowton E., et al. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 74, 1101-1108.
3. Boudanova E., Navaroli D. M., and, Melikian H. E., (2008) Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54, 605-612.
4. Bradford M. M., (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Chen R., Furman C. A., Zhang M., Kim M. N., Gereau R. W. T., Leitges M., and, Gnegy M. E., (2009) Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J. Pharmacol. Exp. Ther. 328, 912-920.
6. Chu P. W., Seferian K. S., Birdsall E., Truong J. G., Riordan J. A., Metcalf C. S., Hanson G. R., and, Fleckenstein A. E., (2008) Differential regional effects of methamphetamine on dopamine transport. Eur. J. Pharmacol. 590, 105-110.
7. Clausing P., Gough B., Holson R. R., Slikker Jr W., and, Bowyer J. F., (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J. Pharmacol. Exp. Ther. 274, 614-621.
8. Connor C. E., and, Kuczenski R., (1986) Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine. Biochem. Pharmacol. 35 (312), 3-3130.
9. Fleckenstein A. E., Metzger R. R., Beyeler M. L., Gibb J. W., and, Hanson G. R., (1997a) Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334, 111-114.
10. Fleckenstein A. E., Metzger R. R., Wilkins D. G., Gibb J. W., and, Hanson G. R., (1997b) Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282, 834-838.
11. Fleckenstein A. E., Volz T. J., Riddle E. L., Gibb J. W., and, Hanson G. R., (2007) New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681-698.
12. Fog J. U., Khoshbouei H., Holy M., et al. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417-429.
13. Foster J. D., Adkins S. D., Lever J. R., and, Vaughan R. A., (2008) Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J. Neurochem. 105, 1683-1699.
14. Fumagalli F., Gainetdinov R. R., Valenzano K. J., and, Caron M. G., (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18, 4861-4869.
15. Granado N., Ares-Santos S., Oliva I., O'Shea E., Martin E. D., Colado M. I., and, Moratalla R., (2011) Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol. Dis. 42, 391-403.
16. Hadlock G. C., Baucum II A. J., King J. L., Horner K. A., Cook G. A., Gibb J. W., Wilkins D. G., Hanson G. R., and, Fleckenstein A. E., (2009) Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. J. Pharmacol. Exp. Ther. 329, 169-174.
17. Hadlock G. C., Chu P. W., Walters E. T., Hanson G. R., and, Fleckenstein A. E., (2010) Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation. J. Pharmacol. Exp. Ther. 335, 207-212.
18. Johnson L. A., Furman C. A., Zhang M., Guptaroy B., and, Gnegy M. E., (2005a) Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49, 750-758.
19. Johnson L. A., Guptaroy B., Lund D., Shamban S., and, Gnegy M. E., (2005b) Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J. Biol. Chem. 280, 10914-10919.
20. Kahlig K. M., Binda F., Khoshbouei H., Blakely R. D., McMahon D. G., Javitch J. A., and, Galli A., (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Nat Acad. Sci. USA 102, 3495-3500.
21. Kokoshka J. M., Metzger R. R., Wilkins D. G., Gibb J. W., Hanson G. R., and, Fleckenstein A. E., (1998) Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res. 799, 78-83.
22. LaVoie M. J., and, Hastings T. G., (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19, 1484-1491.
23. Mack F., and, Bonisch H., (1979) Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn Schmiedebergs Arch. Pharmacol. 310, 1-9.
24. Mark K. A., Soghomonian J. J., and, Yamamoto B. K., (2004) High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J. Neurosci. 24, 11449-11456.
25. Melikian H. E., and, Buckley K. M., (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 7699-7710.
26. Metzger R. R., Haughey H. M., Wilkins D. G., Gibb J. W., Hanson G. R., and, Fleckenstein A. E., (2000) Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J. Pharmacol. Exp. Ther. 295, 1077-1085.
27. Rao A., Simmons D., and, Sorkin A., (2010) Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons. Mol. Cell. Neurosci. 46, 148-158.
28. Richards T. L., and, Zahniser N. R., (2009) Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens. J. Neurochem. 108, 1575-1584.
29. Robertson S. D., Matthies H. J., and, Galli A., (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol. Neurobiol. 39, 73-80.
30. Sandoval V., Riddle E. L., Ugarte Y. V., Hanson G. R., and, Fleckenstein A. E., (2001) Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J. Neurosci. 21, 1413-1419.
31. Saunders C., Ferrer J. V., Shi L., et al. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Nat Acad. Sci. USA 97, 6850-6855.
32. Sorkina T., Hoover B. R., Zahniser N. R., and, Sorkin A., (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6, 157-170.
33. Sulzer D., and, Rayport S., (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron, 5, 797-808.
34. Vaughan R. A., Huff R. A., Uhl G. R., and, Kuhar M. J., (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 15541-15546.
35. Xu M., Chandler L. J., and, Woodward J. J., (2008) Ethanol inhibition of recombinant NMDA receptors is not altered by coexpression of CaMKII-alpha or CaMKII-beta. Alcohol 42, 425-432.
36. Zhou Q. Y., Grandy D. K., Thambi L., et al. (1990) Cloning and expression of human and rat D1 dopamine receptors. Nature 347, 76-80.